Belinda Yen-Lieberman

Belinda Yen-Lieberman

Auto-generated profile, based on publicly available information

Belinda Yen-Lieberman

Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Clinical and Vaccine Immunology
Verified
Journal Article
Open access
PDF file
HKHarriet Mayanja Kizza
Harriet Mayanja Kizza
BRBenigno Rodriguez
Benigno Rodriguez
Miguel Quiñones-MateuMiguel Quiñones-Mateu
Miguel Quiñones-Mateu
MMMuneer Mirza
Muneer Mirza
HAHtin Lin Aung
Htin Lin Aung
ZTZahra Toossi
Zahra Toossi
Tuberculosis (TB) is the most common life-threatening infection in human immunodeficiency virus (HIV)-infected persons and frequently occurs before the onset of severe immunodeficiency. Development of TB is associated with increased HIV type 1 (HIV-1) viral load, a fall in CD4 lymphocyte counts, and increased mortality. The aim of this study was to examine how treatment of pulmonary TB affected HIV-1 activity in HIV-1/TB-coinfected subjects with CD4 cell counts of >100 cells/μl. HIV-1/TB-coinfected subjects were recruited in Kampala, Uganda, and were monitored over time. Based upon a significant (0.5 log10copies/ml) decrease in viral load by the end of treatment, two patient groups could be distinguished. Responders (n= 17) had more rapid resolution of anemia and pulmonary lesions on chest radiography during TB treatment. This group had a significant increase in viral load to levels not different from those at baseline 6 months after completion of TB treatment. HIV-1 viral load in nonresponders (n= 10) with TB treatment increased and at the 6 month follow-up was significantly higher than that at the time of diagnosis of TB. Compared to baseline levels, serum markers of macrophage activation including soluble CD14 decreased significantly by the end of TB treatment in responders but not in nonresponders. These data further define the impact of pulmonary TB on HIV-1 disease. HIV-1 replication during dual HIV-1/TB infection is not amenable to virologic control by treatment of TB alone. Concurrent institution of highly active antiretroviral treatment needs to be evaluated in patients dually infected with pulmonary TB and HIV-1.

1 July 2014 in Journal of the American Society of Cytopathology
Verified
Journal Article
Closed access
DCDeborah J. Chute
Deborah J. Chute
GAGhada T. Aramouni
Ghada T. Aramouni
JBJennifer A. Brainard
Jennifer A. Brainard
AHAaron P. Hoschar
Aaron P. Hoschar
AKAnita Kroeger
Anita Kroeger
BYBelinda Yen-Lieberman
Belinda Yen-Lieberman

1 April 2008 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
SYStephanie Yee-Guardino
Stephanie Yee-Guardino
KGKate Gowans
Kate Gowans
BYBelinda Yen-Lieberman
Belinda Yen-Lieberman
PBPamela Berk
Pamela Berk
DKDebra Kohn
Debra Kohn
JGJohanna Goldfarb
Johanna Goldfarb
We conducted a cross-sectional study of β-herpesviruses in febrile pediatric oncology patients (n = 30), with a reference group of febrile pediatric solid-organ transplant recipients (n = 9). One (3.3%) of 30 cancer patients and 3 (33%) of 9 organ recipients were PCR positive for cytomegalovirus. Four (13%) of 30 cancer patients and 3 (33%) of 9 transplant recipients had human herpesvirus 6B (HHV-6B) DNAemia, which was more common within 6 months of initiation of immune suppression (4 of 16 vs. 0 of 14 cancer patients; p = 0.050). HHV-6A and HHV-7 were not detected. No other cause was identified in children with HHV-6B or cytomegalovirus DNAemia. One HHV-6B–positive cancer patient had febrile disease with concomitant hepatitis. Other HHV-6B–positive children had mild “viral” illnesses, as did a child with primary cytomegalovirus infection. Cytomegalovirus and HHV-6B should be included in the differential diagnosis of febrile disease in children with cancer.

1 September 2017 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
GPGary W. Procop
Gary W. Procop
ATAlan J. Taege
Alan J. Taege
CSColleen Starkey
Colleen Starkey
MTMarisa Tungsiripat
Marisa Tungsiripat
DWDiane Warner
Diane Warner
BYBelinda Yen-Lieberman
Belinda Yen-Lieberman